Nurix Therapeutics (NRIX) Return on Assets [ROA] (2020 - 2026)
Nurix Therapeutics' Return on Assets [ROA] came in at -58.27% for fiscal Q2 2026 (quarter ended May 31, 2026), down 23.90 percentage points from -34.36% a year earlier and down 13.67 percentage points from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Return on Assets [ROA] (2020 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics' Return on Assets [ROA] was -38.96%, down 1.19 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of -19.32 percentage points (FY2020 to FY2025).
- Going back by fiscal year, Return on Assets [ROA] was -37.77% in FY2024 (-0.50 pp), -37.27% in FY2023 (+3.10 pp), -40.37% in FY2022 (-13.53 pp) and -26.85% in FY2021 (-7.21 pp).
- The fiscal Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] in data going back to fiscal Q4 2020.
- Year-over-year, Return on Assets [ROA] has declined for four consecutive quarters, with an average year-over-year change of -2.33 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q1 2025 (a gain of 10.86 percentage points), and the weakest in fiscal Q2 2026 (a drop of 23.90 percentage points).
- Business Quant data shows NRIX's Return on Assets [ROA] at -44.60% (Q1 2026), -43.69% (Q4 2025) and -43.95% (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Nurix Therapeutics | 2.46 Bn | 452.73 Mn | - | -58.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -58.27% |
| Feb 28, 2026 | -44.60% |
| Nov 30, 2025 | -43.69% |
| Aug 31, 2025 | -43.95% |
| May 31, 2025 | -34.36% |
| Feb 28, 2025 | -32.45% |
| Nov 30, 2024 | -32.73% |
| Aug 31, 2024 | -34.54% |
| May 31, 2024 | -40.06% |
| Feb 29, 2024 | -43.32% |
| Nov 30, 2023 | -43.37% |
| Aug 31, 2023 | -45.14% |
| May 31, 2023 | -43.69% |
| Feb 28, 2023 | -45.38% |
| Nov 30, 2022 | -41.17% |
| Aug 31, 2022 | -40.14% |
| May 31, 2022 | -37.13% |
| Feb 28, 2022 | -29.62% |
| Nov 30, 2021 | -24.16% |
| Aug 31, 2021 | -19.67% |
API Access
Nurix Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();